Skip to content

Supports for reducing parenting stress among caregivers of children with allergies and its effects: A randomized controlled trial

Supports for reducing parenting stress among caregivers of children with allergies and its effects: A randomized controlled trial - Supports for reducing parenting stress among caregivers of children with allergies and its effects: A randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000045049
Enrollment
60
Registered
2021-09-01
Start date
2022-10-31
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Allergy

Interventions

The intervention group will receive allergy-related online support and links to existing allergy information once a week. Participants will complete questionnaires sent via online at the start, after

Sponsors

Kinjo Gakuin University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) The primary caregiver of a child who has been diagnosed with one or more of the following allergic diseases (atopic dermatitis, allergic bronchial asthma, allergic rhinitis, food allergy) and is currently undergoing treatment. (2) The child is between 2 and 4 years old and is not enrolled in kindergarten. (3) Written consent for participation in this study has been obtained from the research participant.

Exclusion criteria

Exclusion criteria: (1) The child has chronic disease other than allergy. (2) The primary caregiver is pregnant or may be pregnant. (3) The primary caregiver plans to return to work and enroll the child in kindergarten during the intervention period of the study. (4) The participant does not use a smartphone. (5) Other cases in which the research participant is inappropriate.

Design outcomes

Primary

MeasureTime frame
Comparison of the difference in Parenting Stress Index (PSI) scores between the intervention(Z1) and placebo(Z0) groups at the beginning of the study and after the intervention.

Secondary

MeasureTime frame
Per-protocol/as-treated analysis with intervention group (A1) and placebo group (A0) reconstructed from compliance information of intervention and placebo groups.

Countries

Japan

Contacts

Public ContactChikae Yamaguchi

Kinjo Gakuin University Department of Nursing, Faculty of Nursing

yamaguchi@kinjo-u.ac.jp052-798-0180

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026